BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37910561)

  • 1. CD11c is not required by microglia to convey neuroprotection after prion infection.
    Carroll JA; Striebel JF; Baune C; Chesebro B; Race B
    PLoS One; 2023; 18(11):e0293301. PubMed ID: 37910561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain.
    Bradford BM; McGuire LI; Hume DA; Pridans C; Mabbott NA
    Glia; 2022 Nov; 70(11):2169-2187. PubMed ID: 35852018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction.
    Carroll JA; Striebel JF; Race B; Phillips K; Chesebro B
    J Virol; 2015 Feb; 89(4):2388-404. PubMed ID: 25505076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia in prion diseases.
    Aguzzi A; Zhu C
    J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia Are Critical in Host Defense against Prion Disease.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29769333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 2 confers partial neuroprotection during prion disease.
    Carroll JA; Race B; Williams K; Chesebro B
    PLoS One; 2018; 13(12):e0208559. PubMed ID: 30596651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia have limited influence on early prion pathogenesis, clearance, or replication.
    Race B; Williams K; Baune C; Striebel JF; Long D; Thomas T; Lubke L; Chesebro B; Carroll JA
    PLoS One; 2022; 17(10):e0276850. PubMed ID: 36301895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
    Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
    J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neuroprotective role for microglia in prion diseases.
    Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
    J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation in Prion Disease.
    Li B; Chen M; Zhu C
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia in Prion Diseases: Angels or Demons?
    Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling.
    Nuvolone M; Paolucci M; Sorce S; Kana V; Moos R; Matozaki T; Aguzzi A
    PLoS One; 2017; 12(5):e0177876. PubMed ID: 28545141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation, Microglia, and Cell-Association during Prion Disease.
    Carroll JA; Chesebro B
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30650564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive Toll-like Receptors Gene Expression and Glial Response in Different Brain Regions of Natural Scrapie.
    García-Martínez M; Cortez LM; Otero A; Betancor M; Serrano-Pérez B; Bolea R; Badiola JJ; Garza MC
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Gal-3 Mediates Microglia Activation and Neuroinflammation via the TREM2 Signaling Pathway in Prion Infection.
    Fan Q; Wu YZ; Jia XX; A R; Liu CM; Zhang WW; Chao ZY; Zhou DH; Wang Y; Chen J; Xiao K; Chen C; Shi Q; Dong XP
    ACS Chem Neurosci; 2023 Oct; 14(20):3772-3793. PubMed ID: 37769016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis.
    Li B; Chen M; Aguzzi A; Zhu C
    J Mol Med (Berl); 2021 Jun; 99(6):877-887. PubMed ID: 33758958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/- mice.
    Riemer C; Schultz J; Burwinkel M; Schwarz A; Mok SW; Gültner S; Bamme T; Norley S; van Landeghem F; Lu B; Gerard C; Baier M
    J Virol; 2008 Dec; 82(24):12464-71. PubMed ID: 18842729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype.
    Pankiewicz JE; Lizińczyk AM; Franco LA; Diaz JR; Martá-Ariza M; Sadowski MJ
    Acta Neuropathol Commun; 2021 Sep; 9(1):157. PubMed ID: 34565486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early cytokine elevation, PrPres deposition, and gliosis in mouse scrapie: no effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35.
    Tribouillard-Tanvier D; Race B; Striebel JF; Carroll JA; Phillips K; Chesebro B
    J Virol; 2012 Oct; 86(19):10377-83. PubMed ID: 22787236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.